Antioxidant effects of LEDT in dystrophic muscle cells: involvement of PGC-1α and UCP-3 pathways

Guilherme Luiz da Rocha1, Dimitrius Santiago Passos Simões Fróes Guimarães1,2, Marcos Vinicius da Cruz1,2

  • 1Department of Structural and Functional Biology, Institute of Biology, University of Campinas (UNICAMP), Campinas, SP, 13083-970862, Brazil.

Abstract

Insights

Light-emitting diode therapy (LEDT) reduces oxidative stress and improves mitochondrial function in Duchenne muscular dystrophy (DMD) muscle cells. This therapy shows potential for DMD treatment by enhancing antioxidant defenses and mitochondrial parameters.

Area of Science:

  • Cell Biology
  • Biomedical Engineering
  • Genetics

Background:

  • Reactive oxygen species and mitochondrial dysfunction are key factors in Duchenne muscular dystrophy (DMD) pathophysiology.
  • Light-emitting diode therapy (LEDT) has demonstrated positive effects on dystrophic muscles, but its precise molecular mechanisms, especially antioxidant effects, require further investigation.

Purpose of the Study:

  • To investigate the specific effects of LEDT on oxidative stress and mitochondrial parameters in primary muscle cells from DMD patients.
  • To elucidate the molecular mechanisms underlying LEDT's therapeutic potential in DMD.

Main Methods:

  • Primary muscle cells from mdx mice (a DMD model) were exposed to LEDT at various wavelengths (420, 470, 660, and 850 nm) with a 0.5 J dose.
  • Cells were analyzed 48 hours post-irradiation for oxidative stress markers, antioxidant enzyme activity, biogenesis markers, and mitochondrial function.

Main Results:

  • LEDT significantly reduced hydrogen peroxide (H2O2) production and levels of 4-HNE, catalase, SOD-2, and GR in mdx muscle cells.
  • UCP3 was upregulated across all tested wavelengths, while PGC-1α and mitochondrial electron transport chain complexes (III and V) were upregulated specifically with 850 nm LEDT.
  • LEDT generally increased mitochondrial membrane potential and mass, while decreasing superoxide (O2·-) production.

Conclusions:

  • LEDT demonstrates therapeutic potential for Duchenne muscular dystrophy (DMD) by exerting antioxidant effects.
  • The therapy modulates key molecular pathways, including PGC-1α and UCP3, suggesting a role in improving mitochondrial health and function in DMD.